Skip to main content

Advertisement

SpringerLink
Log in

Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience

  • Brief Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

Hyperthermia (HT) is used to increase the temperature of the tumor-sensitizing cells to the effects of radiation/chemotherapy. We aimed to assess the feasibility, tolerability and safety of hyperthermia treatment in a Radiation Oncology Department.

Methods

Between June 2015 and June 2017, 106 patients and a total of 159 tumor lesions were included in a prospective study (EudraCT 2018-001089-40) of HT concomitant with radiotherapy (RT). Systemic treatment was accepted. HT was given twice a week, 60 min per session, during RT treatment by a regional capacitive device (HY-DEEP 600WM system) at 13.56 MHz radiofrequency.

Results

Most lesions (138 cases, 86.8%) received all HT sessions planned. Thirteen lesions (12 patients) withdrew treatment due to grade ≥3 QMHT toxicity. All these 12 patients completed the prescribed radiotherapy and/or systemic treatment.

Conclusions

Regional hyperthermia is a feasible and safe technique to be used in combination with radiotherapy and systemic treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dewhirst MW, Vujaskovic Z, Jones E, et al. Re-setting the biologic rationale for thermal therapy. Int J Hyperth. 2005;21(8):779–90. https://doi.org/10.1080/02656730500271668.

    Article  Google Scholar 

  2. Peeken JC, Vaupel P, Combs SE. Integrating hyperthermia into modern radiation oncology: what evidence is necessary? Front Oncol. 2017;7:132. https://doi.org/10.3389/fonc.2017.00132.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Datta NR, Puric E, Klingbiel D, et al. Hyperthermia and Radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1073–87. https://doi.org/10.1016/j.ijrobp.2015.12.361.

    Article  PubMed  Google Scholar 

  4. National Comprehensive Cancer Network (NCCN) Guidelines. Version 3.2018—October 2018. Breast Cancer. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 28 January 2019.

  5. Benot S. Efectividad y seguridad de la hipertermia en combinación con radioterapia y/o quimioterapia en el tratamiento del cáncer de mama, cérvix y recto. Agencia Evaluadora de Tecnologías Sanitarias de Andalucia (AETSA). 2004. https://doi.org/10.13140/rg.2.2.21161.90727.

  6. Sahinbas H, Rosch M, Demiray M. Temperature measurements in a capacitive system of deep loco-regional hyperthermia. Electromagn Biol Med. 2017;36(3):248–58. https://doi.org/10.1080/15368378.2017.1307221.

    Article  CAS  PubMed  Google Scholar 

  7. Hamazoe R, Maeta M, Murakami A, et al. Heating efficiency of radiofrequency capacitive hyperthermia for treatment of deep- seated tumors in the peritoneal cavity. J Surg Oncol. 1991;48:176–9 PMID: 1943113.

    Article  CAS  Google Scholar 

  8. Lagendijk JJW, van Rhoon GC, Hornsleth SN, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperth. 1998;14(2):125–33 PMID: 9589319.

    Article  CAS  Google Scholar 

  9. Wust P, Gellermann J, Harder C, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys. 1998;41(5):1129–37. https://doi.org/10.1016/S0360-3016(98)00165.

    Article  CAS  PubMed  Google Scholar 

  10. Crezee H, van Leeuwen CM, Oei AL, et al. Thermoradiotherapy planning: integration in routine clinical practice. Int J Hyperth. 2015;32(1):41–9. https://doi.org/10.3109/02656736.2015.1110757.

    Article  Google Scholar 

  11. Ohguri T, Imada H, Yahara K, et al. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes. Int J Radiat Oncol Biol Phys. 2009;73(1):128–35. https://doi.org/10.1016/j.ijrobp.2008.03.059.

    Article  PubMed  Google Scholar 

  12. Bruggmoser G, Bauchowitz S, Canters R, et al. Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol. 2011;187(10):605–10. https://doi.org/10.1007/s00066-011-1145-x.

    Article  PubMed  Google Scholar 

  13. Bruggmoser G, Bauchowitz S, Canters R, et al. Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia. Quality management in regional deep hyperthermia. Strahlenther Onkol. 2012;188(Suppl 2):198. https://doi.org/10.1007/s00066-012-0176-2.

    Article  PubMed  Google Scholar 

  14. Grupo Español de Hipertermia https://www.hipertermiaoncologica.es/documentos. Accessed 28 January 2019.

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Dr. Negrin Hospital, Barranco de la Ballena s/n, 35010, Las Palmas de Gran Canaria, Spain

    M. Lloret, L. García-Cabrera, A. Hernandez, N. Santana & L. López-Molina

  2. Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain

    M. Lloret

  3. Instituto Canario de Investigación del Cáncer, Las Palmas de Gran Canaria, Spain

    M. Lloret & P. C. Lara

  4. Universidad Fernando Pessoa Canarias, Las Palmas, Spain

    P. C. Lara

  5. Hospital Universitario San Roque, Las Palmas, Spain

    P. C. Lara

Authors
  1. M. Lloret
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. García-Cabrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Santana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. López-Molina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. C. Lara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Lloret.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval (Research involving human participants and/or animals)

All human studies have been approved by the appropriate ethics committee and have, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

All the persons gave their informed consent prior to their inclusion in the study and details that might disclose the identity of the subjects under study were omitted.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lloret, M., García-Cabrera, L., Hernandez, A. et al. Feasibility of a deep hyperthermia and radiotherapy programme for advanced tumors: first Spanish experience. Clin Transl Oncol 21, 1771–1775 (2019). https://doi.org/10.1007/s12094-019-02097-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-019-02097-9

Keywords

Search

Navigation